PTJ
BMY icon

Paul Tudor Jones’s Bristol-Myers Squibb BMY Stock Holding History

Paul Tudor Jones’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47M Buy
42,800
+7,500
+21% +$431K ﹤0.01% 1793
2026
Q1 		$2.14M Sell
35,300
-75,100
-68% -$4.38M ﹤0.01% 1798
2025
Q4 		$5.95M Sell
110,400
-17,700
-14% -$851K 0.01% 1047
2025
Q3 		$5.78M Sell
128,100
-147,700
-54% -$6.9M 0.01% 1098
2025
Q2 		$12.8M Buy
275,800
+246,700
+848% +$12.1M 0.03% 548
2025
Q1 		$1.77M Sell
29,100
-16,000
-35% -$933K 0.01% 1432
2024
Q4 		$2.55M Sell
45,100
-303,600
-87% -$17M 0.01% 1087
2024
Q3 		$18M Buy
348,700
+62,600
+22% +$2.94M 0.07% 207
2024
Q2 		$11.9M Sell
286,100
-4,500
-2% -$201K 0.06% 327
2024
Q1 		$15.8M Sell
290,600
-78,500
-21% -$4M 0.1% 207
2023
Q4 		$18.9M Buy
369,100
+313,300
+561% +$16.4M 0.15% 135
2023
Q3 		$3.24M Sell
55,800
-30,400
-35% -$1.86M 0.03% 692
2023
Q2 		$5.51M Buy
+86,200
New +$5.78M 0.07% 382
2022
Q4 		– Sell
-5,200
Closed -$369K – 2401
2022
Q3 		$369K Sell
5,200
-39,000
-88% -$2.83M 0.01% 1626
2022
Q2 		$3.4M Buy
44,200
+28,100
+175% +$2.14M 0.09% 288
2022
Q1 		$1.18M Buy
16,100
+8,900
+124% +$598K 0.03% 815
2021
Q4 		$448K Sell
7,200
-6,700
-48% -$393K 0.01% 1550
2021
Q3 		$824K Buy
+13,900
New +$915K 0.01% 1295
2020
Q1 		– Sell
-90,000
Closed -$5.78M – 1067
2019
Q4 		$5.78M Sell
90,000
-120,000
-57% -$6.87M 0.26% 74
2019
Q3 		$10.6M Sell
210,000
-200,000
-49% -$9.4M 0.37% 37
2019
Q2 		$18.6M Hold
410,000
– – 0.53% 16
2019
Q1 		$19.6M Buy
+410,000
New +$20.4M 0.81% 12
2015
Q2 		– Sell
-350,000
Closed -$22.6M – 1500
2015
Q1 		$22.6M Buy
+350,000
New +$21.9M 0.72% 17

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Paul Tudor Jones's BMY Position: Q1 2026 in Review

Paul Tudor Jones sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 33,595 shares — an estimated $1.96M sold.

Paul Tudor Jones first reported a position in BMY in Q3 2013 and held it in 37 quarters. The position peaked at $83.1M in Q2 2024. 2,532 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Paul Tudor Jones reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 33,595 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.96M.
  • Paul Tudor Jones first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 37 quarters.
  • Paul Tudor Jones's Bristol-Myers Squibb position peaked at $83.1M in Q2 2024.
  • 2,532 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.